Flex Pharma CEO David Arthur's 2021 pay falls 40% to $677K
Flex Pharma reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Flex Pharma reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, two executives at Flex Pharma received on average a compensation package of $559K, a 32% decrease compared to previous year.
Average pay of disclosed executives at Flex Pharma
David J. Arthur, Chief Executive Officer, received $677K in total, which decreased by 40% compared to 2020. 56% of Arthur's compensation, or $379K, was in salary. Arthur also received $182K in bonus and $116K in other compensation.
Mark J. Rosenblum, Chief Financial Officer, received a compensation package of $442K, which decreased by 15% compared to previous year. 63% of the compensation package, or $278K, was in salary.
Related executives
You may also like
Source: SEC filing on April 28, 2022.